# Dacarbazine

NDC: 63323-128
Generic name: DACARBAZINE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20010907

FDA application: ANDA075371

## Active ingredients

- DACARBAZINE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-128"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-128
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6b97e41-5f15-498c-abfb-d8443ea4d216